Floatz logo

Mylotarg

Acute Promyelocytic Leukemia

Associazione Italiana Ematologia Oncologia Pediatricaantibody_drug_conjugatePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Acute Promyelocytic Leukemia cohort.

Asset / SponsorPhaseRating
Vesanoid
The Affiliated People's Hospital of Ningbo University
Phase 4A
Cytosin-Arabinosid
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 4A
Idarubicine
Technische Universität Dresden
Phase 4A
Arsenic Trioxide
Quetzal Therapeutics
Phase 4BBB
Mitoxantrone
Technische Universität Dresden
Phase 4BBB

View all 50 →

Same molecule, other indications

Mylotarg is also rated in:

Infusions, IntravenousDormant
BB
Indicative ·
66 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
63 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →